Warby Parker Inc. financial data

Symbol
WRBY on NYSE
Industry
Ophthalmic Goods
Location
233 Spring Street, 6 Th Floor East, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
JAND, Inc. (to 3/23/2018)
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 250 % +0.94%
Quick Ratio 43 % -19.2%
Debt-to-equity 91 % +2.46%
Return On Equity -6.17 % +70.6%
Return On Assets -3.23 % +70.9%
Operating Margin -3.9 % +63.7%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 1.41B USD +42.7%
Common Stock, Value, Issued 12K USD 0%
Weighted Average Number of Shares Outstanding, Basic 120M shares +2.55%
Weighted Average Number of Shares Outstanding, Diluted 120M shares +2.55%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 771M USD +15.2%
Operating Income (Loss) -30.1M USD +58.2%
Nonoperating Income (Expense) 10.6M USD +14.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -19.5M USD +68.9%
Income Tax Expense (Benefit) 875K USD +102%
Net Income (Loss) Attributable to Parent -20.4M USD +67.7%
Earnings Per Share, Basic -0.17 USD/shares +68.5%
Earnings Per Share, Diluted -0.17 USD/shares +68.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 254M USD +17.2%
Accounts Receivable, after Allowance for Credit Loss, Current 1.95M USD +9.5%
Inventory, Net 52.3M USD -15.9%
Assets, Current 326M USD +9.19%
Property, Plant and Equipment, Net 170M USD +11.9%
Operating Lease, Right-of-Use Asset 171M USD +40%
Other Assets, Noncurrent 8.7M USD +23.2%
Assets 676M USD +16.6%
Accounts Payable, Current 23.5M USD +4.73%
Employee-related Liabilities, Current 10.4M USD -23.3%
Accrued Liabilities, Current 51.6M USD +11.4%
Contract with Customer, Liability, Current 32.4M USD +2.34%
Liabilities, Current 130M USD +2.57%
Operating Lease, Liability, Noncurrent 205M USD +36.6%
Other Liabilities, Noncurrent 943K USD -25.4%
Liabilities 336M USD +20.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.94M USD -26.8%
Retained Earnings (Accumulated Deficit) -687M USD -3.06%
Stockholders' Equity Attributable to Parent 340M USD +12.7%
Liabilities and Equity 676M USD +16.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 19.9M USD +131%
Net Cash Provided by (Used in) Financing Activities 91K USD +12.3%
Net Cash Provided by (Used in) Investing Activities -16.4M USD -32.7%
Common Stock, Shares Authorized 1.05B shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.49M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 254M USD +17.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 76K USD +52%
Deferred Tax Assets, Valuation Allowance 68.5M USD -1.26%
Deferred Tax Assets, Gross 135M USD +10%
Operating Lease, Liability 225M USD +29.2%
Payments to Acquire Property, Plant, and Equipment 14.4M USD +16.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -20.8M USD +67.5%
Lessee, Operating Lease, Liability, to be Paid 275M USD +31.8%
Property, Plant and Equipment, Gross 329M USD +22.7%
Operating Lease, Liability, Current 20.2M USD -16.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 49.2M USD +32.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 32.3M USD -3.14%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 49.5M USD +45.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 48M USD +32.2%
Deferred Tax Assets, Operating Loss Carryforwards 46.5M USD -5.46%
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 43.1M USD +29.4%
Additional Paid in Capital 1.03B USD +6.09%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 10.6M USD +15.8%
Deferred Tax Assets, Net of Valuation Allowance 66.2M USD +24.8%
Share-based Payment Arrangement, Expense 47.3M USD -32.9%